Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity

Douglas G. Gold; Robert C. Miller; Melva E. Pinn; Thomas G. Osborn; Ivy A. Petersen; Paul D. Brown

doi:10.1016/j.radonc.2007.11.031

Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity

Douglas G. Gold, Robert C. Miller, Melva E. Pinn, Thomas G. Osborn, Ivy A. Petersen, Paul D. Brown

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

No method reliably identifies which patients with connective tissue disorders are at greatest risk of radiotherapy-related complications. Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk.

Original language	English (US)
Pages (from-to)	127-131
Number of pages	5
Journal	Radiotherapy and Oncology
Volume	87
Issue number	1
DOIs	https://doi.org/10.1016/j.radonc.2007.11.031
State	Published - Apr 2008

Keywords

Adverse effects
Connective tissue disorder
Radiotherapy
Scleroderma
Systemic lupus erythematosus
Systemic sclerosis

ASJC Scopus subject areas

Hematology
Oncology
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.radonc.2007.11.031

Cite this

Gold, D. G., Miller, R. C., Pinn, M. E., Osborn, T. G., Petersen, I. A., & Brown, P. D. (2008). Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity. Radiotherapy and Oncology, 87(1), 127-131. https://doi.org/10.1016/j.radonc.2007.11.031

Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity. / Gold, Douglas G.; Miller, Robert C.; Pinn, Melva E. et al.
In: Radiotherapy and Oncology, Vol. 87, No. 1, 04.2008, p. 127-131.

Research output: Contribution to journal › Article › peer-review

@article{b94cb261941f45bd8ee827fa82ccf68b,

title = "Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity",

abstract = "No method reliably identifies which patients with connective tissue disorders are at greatest risk of radiotherapy-related complications. Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk.",

keywords = "Adverse effects, Connective tissue disorder, Radiotherapy, Scleroderma, Systemic lupus erythematosus, Systemic sclerosis",

author = "Gold, {Douglas G.} and Miller, {Robert C.} and Pinn, {Melva E.} and Osborn, {Thomas G.} and Petersen, {Ivy A.} and Brown, {Paul D.}",

year = "2008",

month = apr,

doi = "10.1016/j.radonc.2007.11.031",

language = "English (US)",

volume = "87",

pages = "127--131",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus

T2 - Association with connective tissue disorder severity

AU - Gold, Douglas G.

AU - Miller, Robert C.

AU - Pinn, Melva E.

AU - Osborn, Thomas G.

AU - Petersen, Ivy A.

AU - Brown, Paul D.

PY - 2008/4

Y1 - 2008/4

N2 - No method reliably identifies which patients with connective tissue disorders are at greatest risk of radiotherapy-related complications. Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk.

AB - No method reliably identifies which patients with connective tissue disorders are at greatest risk of radiotherapy-related complications. Building on our prior experience, we postulated that disease severity, as measured by the number of organ systems involved, may predict chronic radiation toxicity risk.

KW - Adverse effects

KW - Connective tissue disorder

KW - Radiotherapy

KW - Scleroderma

KW - Systemic lupus erythematosus

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=41949129417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949129417&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2007.11.031

DO - 10.1016/j.radonc.2007.11.031

M3 - Article

C2 - 18158195

AN - SCOPUS:41949129417

SN - 0167-8140

VL - 87

SP - 127

EP - 131

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - 1

ER -

Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this